Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway

标题
Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway
作者
关键词
NAFLD, T2DM, Insulin resistance, Fat synthesis, MTOR, SREBP-1c
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 148, Issue -, Pages 112697
出版商
Elsevier BV
发表日期
2022-02-15
DOI
10.1016/j.biopha.2022.112697

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started